1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Cisplatin (dose level 4): new trials by email Literature Review of Cisplatin (dose level 4) trials Research Report on Cisplatin (dose level 4)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors Durvalumab, Tremelimumab, Cisplatin (dose level 4) - Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung | Phase 1 | Completed | AstraZeneca | 105 | 2018-05-02 | 2025-01-14 |
Carcinoma, Non-Small-Cell Lung (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
AstraZeneca (1)
Japan (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)
2017 (1)